COMP <GO>
EYE vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
National Vision Holdings Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: EYE 3
— MRK 7
■ METRIC PARITY
LAST: $16.59 (-0.30%) • MKT CAP: $1.32B
options-implied-move
—
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EYE VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EYE | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.40% | 20.70% | -16.30 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.4x | 15.3x | -2.90 | EYE | /valuation <GO> |
| Free Cash Flow Yield | 5.58% | 3.42% | +2.16 | EYE | /fcf-yield <GO> |
| Operating Margin | 3.00% | 34.30% | -31.30 | MRK | /operating-margins <GO> |
| Net Profit Margin | 1.50% | 28.10% | -26.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 9.00% | 1.30% | +7.70 | EYE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.19 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.0 | 51.7 | -5.70 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 41.3x | 18.4x | +22.90 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.32B | $361.02B | -$359.71B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EYE REV | MRK REV | EYE GROSS % | MRK GROSS % | EYE FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.99B | $65.01B | — | 74.8% | $73.5M | $12.36B |
| FY 2024 | $1.82B | $64.17B | — | 76.3% | $38.1M | $18.10B |
| FY 2023 | $1.76B | $60.12B | — | — | $173.0M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EYE // BETA —
MRK // BETA 0.92